MADISON, N.J., Feb. 24, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech Talks" and other programs during the HIMSS 2014 Annual Conference & Exhibition, the industry's largest health IT educational program and exhibition February 23 – 27 in Orlando, Florida.
"Quest serves about half of the physicians and hospitals in the U.S., providing clinicians with diagnostic insights from nearly half a million patient encounters each day. Few organizations have our experience creating secure, large-scale, interoperable networks that facilitate the exchange of health information and transform it into insights for improving health," said Tom Wagner, vice president, healthcare technology solutions, Quest Diagnostics. "Our goal for HIMSS is to share information on these capabilities and the latest advances in our interoperable technology and population health offerings, so physicians and health systems are better positioned to use technology and health information to improve quality, lower costs and deliver better outcomes."
At its exhibit, Quest will feature several health IT products and services, including:
- The Care360™ suite of interoperable electronic health record and connectivity products, used by more than 300,000 physicians in the United States.
- Quest's nine-time award winning ChartMaxx™ enterprise-content management solution, certified for Stage 1 and 2 meaningful use. More than 170 hospitals and health systems use ChartMaxx for secure data and workflow management. ChartMaxx was recently named – for the 9th time -- top KLAS award winner in its category.
- Quest's patient health portal and mobile solution app Gazelle™, which empowers approximately one million users with access to their health records and promotes better health with exchange of diagnostics insights.
- Population health analytics, based on Quest Diagnostics Health Trends™, the largest private clinical database of laboratory data from Quest's more than 1.5 billion patient encounters.
During the three-day event, Quest will hold a series of educational "Tech Talks" by executives and industry thought leaders to help HIMSS attendees learn about advances in technology and information management that are helping Quest's customers deliver better care and value across care settings.
They will also discuss the implications for hospitals, physicians and other providers of a new federal rule that gives patients the ability to directly access their lab results nationally. Prior to the rule, patients in many states were required to request results from a designated healthcare provider rather than directly from the performing laboratory.
At 11:00 AM on Tuesday, February 25, Mr. Wagner will discuss how employers and health systems can promote better health and wellness. Former NY Giants 1990 Super Bowl champion Stephen Baker, 'The Touchdown Maker,' will discuss the value of these wellness programs for athletes and be at the Quest booth for a meet and greet with autograph signing. Mr. Baker will also discuss the significance of Quest Diagnostics partnering with the NY Giants to enhance athletes' health and performance and the opportunity to develop new sports diagnostics product offerings. Quest introduced its new sports diagnostics business in 2013.
During Stephen Baker's meet and greet, Quest will also provide vouchers for complimentary Blueprint for Wellness® screening profiles to the first 100 visitors to the Quest booth. Quest Diagnostics Blueprint for Wellness health-risk identification and improvement services help employees and individuals learn about, and take action to reduce, their personal health risks based on diagnostic insights. For more information, visit BlueprintForWellness.com.
For the schedule for Quest's HIMSS "Tech Talks": http://www.questdiagnostics.com/home/physicians/chartmaxx/himss/presentations.html
To learn more about what Quest HIT solutions to be on display at HIMSS: http://www.questdiagnostics.com/home/physicians/chartmaxx/himss.html
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.
HIMSS is a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.
Contacts: Jenny Dudikoff, K P (Media at HIMSS): 916-498-7713 Wendy Bost, Quest Diagnostics (Media): 973-520-2800 Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900
SOURCE Quest Diagnostics